ISRCTN88709771已完成未知
eutrophil Gelatinase Associated Lipocalin (NGAL) as a predictor of acute kidney injury post coronary angiogram: a cohort observational study
Randox Laboratories (UK)0 个研究点目标入组 300 人开始时间: 2012年3月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 300
研究概览
简要总结
2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29069419 [added 18/01/2019]
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Age > 18 years
- •2. Presenting for angiogram with known chronic kidney disease (CKD) [glomerular filtration rate (GFR) < 60mls/min]
排除标准
- •1. Myocardial infarction (MI) or acute coronary syndrome within previous 6 weeks
- •2. Hospitalisation within previous 6 weeks
- •3. Decompensated heart failure
- •4. Inability to give informed consent
研究者
相似试验
招募中
不适用
eutrophil Gelatinase-Associated Lipocalin as an early detector of ischemic tubular injury in patients admitted to a general Intensive Care Unit.Acute renal dysfunctionkidney failure10038430NL-OMON31307Erasmus MC, Universitair Medisch Centrum Rotterdam700
已完成
不适用
GAL an early biomarker for acute kidney injuryAKIBiomarkersNL-OMON21935-700
尚未招募
不适用
Serum NGAL IN Patients With Multiple MyelomaMultiple Myeloma(MM)NCT05439538Assiut University60
已完成
不适用
Plasma Neutrophil Gelatinase-Associated Lipocalin in ICU patients with acute renal failureICU patients with acute renal failureJPRN-UMIN000006349Osaka University Hospital50
招募中
不适用
se of Urinary Neutrophil Gelatinase Associated Lipocalin (uNGAL) in predicting spontaneous bacterial peritonitis in cirrhosis.CTRI/2021/09/036783Taurus Life Sciences Company